<img alt="" height="1" width="1" />Astellas buys Japan, other rights to new IBS drugReutersT), Japan's No.2 drugmaker, said on Tuesday it will buy the rights to develop and sell US firm Ironwood Pharmaceuticals' drug for irritable bowel syndrome ...Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide<nobr>Earthtimes (press release)</nobr>Astellas buys Asian rights to Ironwood's IBS drug<nobr>Pharma Times</nobr><nobr>all 17 news articles »</nobr> |